The aim of this study was to evaluate the efficacy and safety of transradial percutaneous coronary intervention (TRI) com pared with transfemoral percutaneous coronary intervention (TFI) in patients with ischemic heart disease. Methods: We reviewed retrospectively the medical records including imaging data of the patients with ischemic heart disease who underwent TRI or TFI from January 2007 to December 2009 in Soonchunhyang University Seoul Hospital. We compared major ad verse cardiac and cerebrovascular events (MACCEs) including death, myocardial infarction, revascularization, stent thrombosis, and cerebrovascular accident during followup period. We also compared procedure related vascular complications including hema toma, arteriovenous fistula, pseudoaneurysm, and infection. Results: Total number of patients was 347 (256 patients of TRI and 91 patients of TFI). There were no significant differences in the rate of MACCEs between two groups. There were significantly less procedurerelated vascular complications in TRI group (3.1% vs. 11.0%, P= 0.010). Conclusion: TRI is as effective as TFI with no difference in the rate of MACCEs in patients with ischemic heart disease. TRI is superior to TFI in safety with reduction of vascular complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.